Search Results - "Hirakawa, Kouichi"

Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure by Aoki, Tatsuya, Wada, Mikio, Kawashima, Atsushi, Hirakawa, Kouichi, Nagata, Akihiro, Kagawa, Keizo

“…A 66-year-old man with a several year history of thrombocytopenia, pleural effusion and ascites, anasarca, and organomegaly presented with general fatigue,…”
Get full text

ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION by Ogawa, Takahiro, Oowada, Kei, Tanba, Kazuna, Hirakawa, Kouichi

Get full text

Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression by Kaneko, H, Horiike, S, Nakai, H, Ueda, Y, Nakao, M, Hirakawa, K, Yokota, S, Taniwaki, M, Misawa, S, Kashima, K

“…Neurofibromatosis 1 gene (NF1) is a tumor suppressor gene and the product of which down-regulates Nras protein by its GTPase activating protein-related domain…”
Get more information

Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia by Horiike, S, Misawa, S, Kaneko, H, Nakai, H, Ueda, Y, Nakao, M, Hirakawa, K, Taniwaki, M, Kashima, K

“…We report a patient with acute myelomonocytic leukemia (AMMoL) who showed two independent point mutations of the N-ras gene at codons 12 and 13. Longitudinal…”
Get more information

Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells by KIMURA, S, MAEKAWA, T, HIRAKAWA, K, MURAKAMI, A, ABE, T

“…This study was designed using c-myc antisense oligodeoxynucleoside phosphorothioate (AS PS-ODN) to evaluate how alterations of c-myc expression in HL-60 human…”
Get full text

Three-dimensional CT imaging in the evaluation of fracture of the jaws by Kishi, Kanji, Fujiki, Tomokazu, Hirakawa, Kouichi, Hasegawa, Isao, Uemura, Masato, Adachi, Kiyoyuki, Shigehara, Hiroshi, Yamamoto, Michinori, Hiraki, Yoshio

Get full text

A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases by Misawa, S, Tsuda, S, Taniwaki, M, Horiike, S, Ariyama, Y, Hirakawa, K, Ueda, Y, Kaneko, H, Nakao, M, Kashima, K

“…A combination antibacterial therapy with fosfomycin (FOM) and sulbactam/cefoperazone (SBT/CPZ) was applied to 78 patients with severe infections associated…”
Get more information

Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders by Hirakawa, K, Tsuda, S, Misawa, S, Ueda, Y, Kaneko, H, Nakao, M, Ariyama, Y, Nakai, H, Seriu, T, Takashima, T

“…We evaluated clinical effects and toxicities of a combination of fosfomycin (FOM) and clavulanic acid/ticarcillin (CVA/TIPC) for treatment of infections…”
Get more information

Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders by Hirakawa, K, Tsuda, S, Misawa, S, Kuzuyama, Y, Nakai, H, Seriu, T, Takashima, T, Tanaka, S, Nishigaki, H, Yokota, S

“…We evaluated clinical effects and toxicities of a combination in treatment with cefodizime (CDZM) and minocycline (MINO) for infections complicated with…”
Get more information

Sequence specificity on the growth suppression and induction of apoptosis of chronic myeloid leukemia cells by BCR-ABL anti-sense oligodeoxynucleoside phosphorothioates by Maekawa, T, Kimura, S, Hirakawa, K, Murakami, A, Zon, G, Abe, T

“…Sequence specificity of inhibitory effects of various BCR-ABL anti-sense oligodeoxynucleoside phosphorothioates (AS PS-ODN) on the proliferation of the chronic…”
Get more information